NVAX · Insider Trading
Novavax Inc
Every open-market purchase and sale reported by NVAX officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-23 | Charles W. Newton | Director | A | +35,450 deriv. | — |
| 2026-06-23 | Richard J Rodgers | Director | M | +18,880 | — |
| 2026-06-23 | David M Mott | Director | M | +18,880 | — |
| 2026-06-23 | Richard Douglas | Director | M | +18,880 | — |
| 2026-06-23 | Rachel K. King | Director | M | +18,880 | — |
| 2026-06-23 | Margaret G McGlynn | Director | M | +18,880 | — |
| 2026-06-23 | John W. Shiver | Director | A | +35,450 deriv. | — |
| 2026-06-23 | Gregg H Alton | Director | M | +18,880 | — |
| 2026-04-28 | Charles W. Newton | Director | M | +9,520 | — |
| 2026-04-16 | Robert Edward Walker | EVP, R&D | A | +165,500 deriv. | — |
| 2026-03-12 | John W. Shiver | Director | M | +7,947 | — |
| 2026-03-09 | Mark J Casey | EVP, Chief Legal Officer | A | +152,000 deriv. | — |
| 2026-03-09 | Ruxandra Draghia-Akli | EVP, Research & Development | A | +139,500 deriv. | — |
| 2026-03-09 | James Patrick Kelly | EVP, CFO and Treasurer | A | +194,000 deriv. | — |
| 2026-03-09 | Elaine O'Hara | EVP, Chief Strategy Officer | A | +177,500 deriv. | — |
| 2026-03-09 | John C Jacobs | President and CEO | A | +551,500 deriv. | — |
| 2026-03-09 | James Patrick Kelly | EVP, CFO and Treasurer | MIXED | +6,319 | −$58.92K |
| 2026-03-05 | John C Jacobs | President and CEO | MIXED | +80,879 | −$657.54K |
| 2026-03-05 | Elaine O'Hara | EVP, Chief Strategy Officer | MIXED | +33,905 | −$212.85K |
| 2026-03-05 | James Patrick Kelly | EVP, CFO and Treasurer | MIXED | +22,317 | −$197.87K |
| 2026-03-05 | Mark J Casey | EVP, Chief Legal Officer | MIXED | +26,122 | −$107.98K |
| 2026-03-05 | Ruxandra Draghia-Akli | EVP, Research & Development | MIXED | +15,354 | −$107.36K |
| 2026-03-03 | Elaine O'Hara | EVP, Chief Strategy Officer | MIXED | +43,256 | −$165.73K |
| 2026-03-03 | John C Jacobs | President and CEO | MIXED | +44,883 | −$389.88K |
| 2026-03-03 | Mark J Casey | EVP, Chief Legal Officer | MIXED | +2,786 | −$12.31K |
| 2026-03-03 | James Patrick Kelly | EVP, CFO and Treasurer | MIXED | +30,300 | −$287.63K |
| 2026-01-26 | John C Jacobs | President and CEO | MIXED | +44,065 | −$358.84K |
| 2025-12-15 | Mark J Casey | EVP, Chief Legal Officer | MIXED | +29,186 | −$85.05K |
| 2025-11-13 | Ruxandra Draghia-Akli | Section 16 | MIXED | +8,209 | −$44.76K |
| 2025-10-30 | Richard J Rodgers | Director | M | +3,800 | — |
| 2025-06-24 | Margaret G McGlynn | Director | A | +47,210 deriv. | — |
| 2025-06-24 | Richard Douglas | Director | A | +47,210 deriv. | — |
| 2025-06-24 | Gregg H Alton | Director | A | +47,210 deriv. | — |
| 2025-06-24 | David M Mott | Director | A | +47,210 deriv. | — |
| 2025-06-24 | Richard J Rodgers | Director | A | +47,210 deriv. | — |
| 2025-06-24 | Rachel K. King | Director | A | +47,210 deriv. | — |
| 2025-06-16 | Gregg H Alton | Director | M | +10,420 | — |
| 2025-06-16 | Margaret G McGlynn | Director | M | +10,420 | — |
| 2025-06-13 | Rachel K. King | Director | M | +10,420 | — |
| 2025-06-13 | David M Mott | Director | M | +10,420 | — |
| 2025-06-13 | Richard Douglas | Director | M | +10,420 | — |
| 2025-06-13 | Richard J Rodgers | Director | M | +10,420 | — |
| 2025-04-29 | Charles W. Newton | Director | A | +71,400 deriv. | — |
| 2025-03-12 | John W. Shiver | Director | A | +59,610 deriv. | — |
| 2025-03-11 | John Trizzino | President and COO | MIXED | +14,936 | −$116.38K |
| 2025-03-11 | James Patrick Kelly | EVP, CFO and Treasurer | MIXED | +6,319 | −$49.24K |
| 2025-03-05 | Ruxandra Draghia-Akli | Section 16 | A | +200,000 deriv. | — |
| 2025-03-05 | John C Jacobs | President and CEO | A | +1,126,500 deriv. | — |
| 2025-03-05 | James Patrick Kelly | EVP, CFO and Treasurer | A | +324,000 deriv. | — |
| 2025-03-05 | Mark J Casey | EVP, Chief Legal Officer | A | +281,500 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| John C Jacobs | President and CEO | 225,680 | $2.46M |
| Elaine O'Hara | EVP, Chief Strategy Officer | 134,642 | $1.47M |
| James Patrick Kelly | EVP, CFO and Treasurer | 130,599 | $1.42M |
| Mark J Casey | EVP, Chief Legal Officer | 90,067 | $980.83K |
| John Trizzino | President and COO | 82,015 | $893.14K |
| David M Mott | Director | 79,770 | $868.70K |
| Richard Douglas | Director | 73,220 | $797.37K |
| James F Young | Director | 58,660 | $638.81K |
| Gregg H Alton | Director | 47,685 | $519.29K |
| Richard J Rodgers | Director | 47,370 | $515.86K |
| Rachel K. King | Director | 45,170 | $491.90K |
| Margaret G McGlynn | Director | 44,468 | $484.26K |
| Ruxandra Draghia-Akli | EVP, Research & Development | 23,563 | $256.60K |
| Charles W. Newton | Director | 9,520 | $103.67K |
| John W. Shiver | Director | 7,947 | $86.54K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the NVAX quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.